Trials / Completed
CompletedNCT02856516
Glycemic Response to Three Oral Nutrition Supplements in Persons With Type 2 Diabetes Mellitus
Plasma Glucose and Insulin Response to Three Oral Nutrition Supplements in Persons With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This will be a randomized, cross-over design. Subjects will be randomized to one of three interventions on three separate study days, 1 week apart.
Detailed description
Following consent, subjects will be randomized to one of three arms. After an overnight fast an intravenous line will be placed for blood withdrawal. The subject will then consume the randomly assigned intervention. Blood samples for glucose and insulin levels will be drawn at specified intervals after the product has been consumed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Boost Glucose Control (A) | Oral nutrition supplement |
| OTHER | Boost Glucose Control (B) | Oral nutrition supplement |
| OTHER | Boost Original | Oral nutrition supplement |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2016-08-01
- Completion
- 2016-09-01
- First posted
- 2016-08-05
- Last updated
- 2016-10-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02856516. Inclusion in this directory is not an endorsement.